No abstract available
Keywords:
cGMP; heart failure; phosphodiesterase 5; preserved ejection fraction; soluble guanylate cyclase.
MeSH terms
-
Animals
-
Cardiovascular Agents / therapeutic use*
-
Cyclic GMP / metabolism*
-
Drug Design
-
Heart Failure / drug therapy*
-
Heart Failure / metabolism
-
Heart Failure / physiopathology
-
Humans
-
Molecular Targeted Therapy*
-
Second Messenger Systems / drug effects*
-
Stroke Volume*
-
Ventricular Function, Left / drug effects*
Substances
-
Cardiovascular Agents
-
Cyclic GMP